Application of computational methods for class A GPCR Ligand discovery

J Mol Graph Model. 2023 Jun:121:108434. doi: 10.1016/j.jmgm.2023.108434. Epub 2023 Feb 21.

Abstract

G protein-coupled receptors (GPCR) are integral membrane proteins of considerable interest as targets for drug development due to their role in transmitting cellular signals in a multitude of biological processes. Of the six classes categorizing GPCR (A, B, C, D, E, and F), class A contains the largest number of therapeutically relevant GPCR. Despite their importance as drug targets, many challenges exist for the discovery of novel class A GPCR ligands serving as drug precursors. Though knowledge of the structural and functional characteristics of GPCR has grown significantly over the past 20 years, a large portion of GPCR lack reported, experimentally determined structures. Furthermore, many GPCR have no known endogenous and/or synthetic ligands, limiting further exploration of their biochemical, cellular, and physiological roles. While many successes in GPCR ligand discovery have resulted from experimental high-throughput screening, computational methods have played an increasingly important role in GPCR ligand identification in the past decade. Here we discuss computational techniques applied to GPCR ligand discovery. This review summarizes class A GPCR structure/function and provides an overview of many obstacles currently faced in GPCR ligand discovery. Furthermore, we discuss applications and recent successes of computational techniques used to predict GPCR structure as well as present a summary of ligand- and structure-based methods used to identify potential GPCR ligands. Finally, we discuss computational hit list generation and refinement and provide comprehensive workflows for GPCR ligand identification.

Keywords: Computer-aided drug design; Docking; Fragment-based drug design; GPCR; Homology modeling; Ligand discovery; Loop modeling; Pharmacophore modeling; Similarity searching; Virtual screening.

Publication types

  • Review

MeSH terms

  • Binding Sites
  • Drug Design*
  • Ligands
  • Receptors, G-Protein-Coupled* / chemistry
  • Signal Transduction

Substances

  • Receptors, G-Protein-Coupled
  • Ligands